MPWT
RPRX icon

MassMutual Private Wealth & Trust’s Royalty Pharma RPRX Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$78.3K Sell
1,396
-25
-2% -$1.3K ﹤0.01% 641
2026
Q1 		$68.2K Buy
1,421
+16
+1% +$701 ﹤0.01% 665
2025
Q4 		$54.3K Sell
1,405
-103
-7% -$3.93K ﹤0.01% 767
2025
Q3 		$53.2K Buy
1,508
+150
+11% +$5.43K ﹤0.01% 780
2025
Q2 		$48.9K Buy
1,358
+402
+42% +$13.3K ﹤0.01% 790
2025
Q1 		$29.8K Buy
956
+414
+76% +$13.1K ﹤0.01% 881
2024
Q4 		$13.8K Buy
542
+166
+44% +$4.4K ﹤0.01% 1139
2024
Q3 		$10.6K Sell
376
-62
-14% -$1.72K ﹤0.01% 1113
2024
Q2 		$11.6K Buy
438
+2
+0.5% +$55 ﹤0.01% 1044
2024
Q1 		$13.2K Buy
436
+18
+4% +$531 ﹤0.01% 952
2023
Q4 		$11.7K Buy
418
+312
+294% +$8.57K ﹤0.01% 961
2023
Q3 		$2.88K Sell
106
-93
-47% -$2.76K ﹤0.01% 1397
2023
Q2 		$6.12K Buy
199
+50
+34% +$1.69K ﹤0.01% 1147
2023
Q1 		$5.37K Buy
149
+113
+314% +$4.19K ﹤0.01% 1139
2022
Q4 		$1K Sell
36
-108
-75% -$4.51K ﹤0.01% 1527
2022
Q3 		$6K Buy
144
+109
+311% +$4.66K ﹤0.01% 903
2022
Q2 		$1K Buy
35
+3
+9% +$123 ﹤0.01% 1397
2022
Q1 		$1K Buy
32
+12
+60% +$471 ﹤0.01% 1406
2021
Q4 		$1K Buy
+20
New +$777 ﹤0.01% 1296

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MassMutual Private Wealth & Trust's RPRX Position: Q2 2026 in Review

MassMutual Private Wealth & Trust reduced its Royalty Pharma (RPRX) stake by 1.8% in Q2 2026, selling an estimated $1.3K and leaving 1,396 shares worth $78.3K. The position accounts for ﹤0.01% of the portfolio, ranked #641.

MassMutual Private Wealth & Trust first reported a position in RPRX in Q4 2021 and has held it in 19 quarters since. 646 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • MassMutual Private Wealth & Trust held 1,396 shares of Royalty Pharma worth $78.3K as of Q2 2026.
  • MassMutual Private Wealth & Trust sold 25 Royalty Pharma shares in Q2 2026, an estimated $1.3K.
  • Royalty Pharma made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #641 holding.
  • MassMutual Private Wealth & Trust first reported a position in Royalty Pharma in Q4 2021 and has held it in 19 quarters since.
  • 646 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.